Emerging research highlights the power of physiological peptides and combined agonists to transform therapeutic strategies for metabolic diseases. These innovative compounds offer the unique feature to simultaneously stimulate multiple receptors, circumventing the challenges of traditional single-target treatments. By optimizing tissue signaling, t